Group One Trading’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Sell |
64,700
-15,500
| -19% | -$257K | ﹤0.01% | 2775 |
|
|
2026
Q1 | $1.3M | Buy |
+80,200
| New | +$1.42M | ﹤0.01% | 2463 |
|
|
2025
Q4 | – | Sell |
-7,300
| Closed | -$107K | – | 9140 |
|
|
2025
Q3 | $107K | Buy |
+7,300
| New | +$92.2K | ﹤0.01% | 5283 |
|
|
2024
Q2 | – | Sell |
-200
| Closed | -$1.79K | – | 7468 |
|
|
2024
Q1 | $1.79K | Buy |
+200
| New | +$1.85K | ﹤0.01% | 6510 |
|
|
2023
Q3 | – | Sell |
-1,300
| Closed | -$13.5K | – | 8291 |
|
|
2023
Q2 | $13.5K | Sell |
1,300
-700
| -35% | -$7.73K | ﹤0.01% | 6224 |
|
|
2023
Q1 | $21.7K | Buy |
2,000
+900
| +82% | +$9.52K | ﹤0.01% | 5445 |
|
|
2022
Q4 | $12.3K | Sell |
1,100
-19,600
| -95% | -$206K | ﹤0.01% | 5916 |
|
|
2022
Q3 | $210K | Buy |
20,700
+20,600
| +20,600% | +$193K | ﹤0.01% | 4101 |
|
|
2022
Q2 | $1K | Sell |
100
-11,300
| -99% | -$104K | ﹤0.01% | 7624 |
|
|
2022
Q1 | $109K | Buy |
+11,400
| New | +$112K | ﹤0.01% | 5408 |
|
|
2021
Q4 | – | Sell |
-74,500
| Closed | -$551K | – | 8824 |
|
|
2021
Q3 | $551K | Buy |
+74,500
| New | +$833K | ﹤0.01% | 4083 |
|
|
2020
Q2 | – | Sell |
-5,000
| Closed | -$116K | – | 6163 |
|
|
2020
Q1 | $116K | Buy |
5,000
+3,000
| +150% | +$75.1K | ﹤0.01% | 3185 |
|
|
2019
Q4 | $52K | Buy |
+2,000
| New | +$38.9K | ﹤0.01% | 3986 |
|
|
2019
Q3 | – | Sell |
-76,800
| Closed | -$1.25M | – | 5540 |
|
|
2019
Q2 | $1.25M | Buy |
76,800
+26,800
| +54% | +$543K | 0.01% | 1444 |
|
|
2019
Q1 | $1.13M | Buy |
+50,000
| New | +$1.27M | 0.01% | 1320 |
|
|
2018
Q2 | – | Sell |
-200
| Closed | -$5K | – | 5464 |
|
|
2018
Q1 | $5K | Buy |
+200
| New | +$5.49K | ﹤0.01% | 4513 |
|
|
2017
Q4 | – | Sell |
-4,300
| Closed | -$147K | – | 5216 |
|
|
2017
Q3 | $147K | Buy |
+4,300
| New | +$141K | ﹤0.01% | 2986 |
|
|
2017
Q1 | – | Sell |
-2,500
| Closed | -$80K | – | 4989 |
|
|
2016
Q4 | $80K | Sell |
2,500
-14,600
| -85% | -$453K | ﹤0.01% | 2977 |
|
|
2016
Q3 | $620K | Buy |
17,100
+13,600
| +389% | +$379K | 0.01% | 1660 |
|
|
2016
Q2 | $79K | Buy |
+3,500
| New | +$75.6K | ﹤0.01% | 3025 |
|
|
2015
Q4 | – | Sell |
-90,000
| Closed | -$989K | – | 5091 |
|
|
2015
Q3 | $989K | Buy |
90,000
+88,800
| +7,400% | +$1.13M | 0.01% | 1252 |
|
|
2015
Q2 | $16K | Buy |
+1,200
| New | +$18.6K | ﹤0.01% | 4140 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
Group One Trading's TBPH Position: Q2 2026 in Review
Group One Trading reduced its Theravance Biopharma (TBPH) stake by 46% in Q2 2026, selling an estimated $100K and leaving 7,057 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #4692.
Group One Trading first reported a position in TBPH in Q2 2014 and has held it in 24 quarters since. The position peaked at $973K in Q2 2019. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.
- Group One Trading held 7,057 shares of Theravance Biopharma worth $120K as of Q2 2026.
- Group One Trading sold 6,068 Theravance Biopharma shares in Q2 2026, an estimated $100K.
- Theravance Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4692 holding.
- Group One Trading first reported a position in Theravance Biopharma in Q2 2014 and has held it in 24 quarters since.
- Group One Trading's Theravance Biopharma position peaked at $973K in Q2 2019.
- 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.